Status:
UNKNOWN
Male Suicide and Metacognition
Lead Sponsor:
Greater Manchester Mental Health NHS Foundation Trust
Conditions:
Suicide, Attempted
Eligibility:
MALE
16+ years
Brief Summary
Suicide is the act of killing oneself and accounts for one death every 40 seconds around the world. In the UK, over 75% of suicides are completed by men. Suicidal ideation is a symptom of depression a...
Detailed Description
The reduction of suicide is a priority for the Department of Health and Social Care which recommends focusing research and interventions on high-risk groups, such as men. 75% of suicides in the UK are...
Eligibility Criteria
Inclusion
- Men aged 16+ who are currently receiving care from the Home Based Treatment Team and are experiencing suicidal thoughts and behaviours
- Men with a primary mental health diagnosis of anxiety, depression, acute stress reaction or adjustment disorder, or men with no diagnosis at all
- Men who are able to provide written, informed consent
Exclusion
- Women will not be eligible as the aim of this study is to investigate masculinity and its impact on suicidality and help-seeking
- Diagnosis of a severe and enduring mental illness such as Schizophrenia or Bipolar Affective Disorder will be excluded, as their suicidality may be secondary to their diagnosis and more suitable to research within that context
- Non-English-speaking as interviews and assessments will be completed in the English language and are not validated in other languages.
- Unable to provide written, informed consent
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04796116
Start Date
April 1 2021
End Date
January 1 2022
Last Update
March 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Greater Manchester Mental Health NHS Foundation Trust
Manchester, United Kingdom, M2553BL